[1]
Mimidis, K., Papadopoulos, V.P., Elefsiniotis, I., Koliouskas, D., Ketikoglou, I., Paraskevas, E., Kanatakis, S., Chrysagis, D., Dalekos, G.N., Tzathas, C., Protopapas, A., Gigi, E., Tsianos, E. and Kartalis, G. 2006. Hepatitis C Virus Survival Curve Analysis in Naïve Patients Treated with PegInterferon α-2b Plus Ribavirin. A Randomized Controlled Trial for Induction with High Doses of PegInterferon and Predictability of Sustained Viral Response from Early Virologic Da. Journal of Gastrointestinal and Liver Diseases. 15, 3 (Sep. 2006), 213–219.